NT-3 Levels and Function in Individuals With CMT

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Zarife Sahenk
Study ID
NCT05011006
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Charcot-Marie-Tooth Disease
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Peripheral Neuropathy

Eligibility Criteria

Sex
ALL
Age
7 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • NT3 blood draw — DIAGNOSTIC_TEST
    blood draw

Study Details

This study will assess the serum NT-3 levels in individuals with the diagnosis of peripheral neuropathy or any type of Charcot-Marie-Tooth Neuropathy (CMT) and correlate this with function.

Key Dates

Start date
Nov 13, 2027
Status verified
Jun 2025
Primary completion
Jun 30, 2030
Completion
Jun 30, 2030

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Assess change in Manual Muscle Testing (MMT) [ Time Frame: Compare baseline to Year 1 and Year 2 visits. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Nationwide Children's HospitalColumbusOhio43205
Dawn Scott
[email protected]
(614)7222715

Find similar trials in Columbus, OH

By research site
Nationwide Children's Hospital· Columbus, OH

Related Studies